Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.862
https://www.valueinhealthjournal.com/article/S1098-3015(14)02792-2/fulltext
Title :
Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02792-2&doi=10.1016/j.jval.2014.08.862
First page :
A391
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
376